Mark J. Gergen

2015 - Mirati Therapeutics

In 2015, Mark J. Gergen earned a total compensation of $1.1M as Former Executive Vice President and Chief Operations Officer at Mirati Therapeutics, a 16% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$134,800
Option Awards$525,600
Salary$396,286
Other$2,814
Total$1,059,500

Gergen received $525.6K in option awards, accounting for 50% of the total pay in 2015.

Gergen also received $134.8K in non-equity incentive plan, $396.3K in salary and $2.8K in other compensation.

Rankings

In 2015, Mark J. Gergen's compensation ranked 7,670th out of 13,638 executives tracked by ExecPay. In other words, Gergen earned more than 43.8% of executives.

ClassificationRankingPercentile
All
7,670
out of 13,638
44th
Division
Manufacturing
2,904
out of 5,187
44th
Major group
Chemicals And Allied Products
1,052
out of 1,857
43rd
Industry group
Drugs
849
out of 1,531
45th
Industry
Pharmaceutical Preparations
666
out of 1,179
44th
Source: SEC filing on April 20, 2017.

Gergen's colleagues

We found three more compensation records of executives who worked with Mark J. Gergen at Mirati Therapeutics in 2015.

2015

Charles Baum

Mirati Therapeutics

Chief Executive Officer

2015

Isan Chen

Mirati Therapeutics

Executive Vice President and Chief Medical and Development Officer

2015

James Christensen

Mirati Therapeutics

Chief Scientific Officer

News

You may also like